Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC

BACKGROUND: Pioglitazone, a synthetic peroxisome proliferator activated receptor (PPAR-γ) ligand, is known as an antidiabetic drug included in the thiazolidinediones (TZDs) class. It regulates the lipid and glucose cell metabolism and recently a role in the inhibition of numerous cancer cell process...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciaramella, Vincenza, Sasso, Ferdinando Carlo, Di Liello, Raimondo, Corte, Carminia Maria Della, Barra, Giusi, Viscardi, Giuseppe, Esposito, Giovanna, Sparano, Francesca, Troiani, Teresa, Martinelli, Erika, Orditura, Michele, De Vita, Ferdinando, Ciardiello, Fortunato, Morgillo, Floriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485164/
https://www.ncbi.nlm.nih.gov/pubmed/31027492
http://dx.doi.org/10.1186/s13046-019-1176-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485164/
https://www.ncbi.nlm.nih.gov/pubmed/31027492
http://dx.doi.org/10.1186/s13046-019-1176-1

Ejemplares similares